Logo image of DCT

Duck Creek Technologies Inc (DCT) Stock Fundamental Analysis

NASDAQ:DCT - Nasdaq - US2641201064 - Common Stock - Currency: USD

18.99  0 (0%)

After market: 18.99 0 (0%)

Fundamental Rating

4

Taking everything into account, DCT scores 4 out of 10 in our fundamental rating. DCT was compared to 283 industry peers in the Software industry. DCT has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, DCT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DCT had positive earnings in the past year.
In the past year DCT had a positive cash flow from operations.
DCT had negative earnings in each of the past 5 years.
DCT had a positive operating cash flow in 4 of the past 5 years.
DCT Yearly Net Income VS EBIT VS OCF VS FCFDCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

1.2 Ratios

The profitability ratios for DCT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCT Yearly ROA, ROE, ROICDCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -1 -2 -3 -4

1.3 Margins

DCT's Gross Margin of 56.63% is on the low side compared to the rest of the industry. DCT is outperformed by 63.00% of its industry peers.
In the last couple of years the Gross Margin of DCT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
DCT Yearly Profit, Operating, Gross MarginsDCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 40

More info and screens

8

2. Health

2.1 Basic Checks

DCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DCT has been increased compared to 1 year ago.
There is no outstanding debt for DCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DCT Yearly Shares OutstandingDCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
DCT Yearly Total Debt VS Total AssetsDCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 15.48 indicates that DCT is not in any danger for bankruptcy at the moment.
DCT has a better Altman-Z score (15.48) than 95.33% of its industry peers.
DCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.48
ROIC/WACCN/A
WACC12.39%
DCT Yearly LT Debt VS Equity VS FCFDCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

DCT has a Current Ratio of 4.68. This indicates that DCT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.68, DCT belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
A Quick Ratio of 4.68 indicates that DCT has no problem at all paying its short term obligations.
The Quick ratio of DCT (4.68) is better than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.68
DCT Yearly Current Assets VS Current LiabilitesDCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
Looking at the last year, DCT shows a quite strong growth in Revenue. The Revenue has grown by 12.81% in the last year.
Measured over the past years, DCT shows a quite strong growth in Revenue. The Revenue has been growing by 14.09% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%

3.2 Future

Based on estimates for the next years, DCT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.83% on average per year.
Based on estimates for the next years, DCT will show a quite strong growth in Revenue. The Revenue will grow by 14.02% on average per year.
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCT Yearly Revenue VS EstimatesDCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DCT Yearly EPS VS EstimatesDCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.05 0.1 0.15 0.2 0.25

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 189.90, the valuation of DCT can be described as expensive.
DCT's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.11. DCT is valued rather expensively when compared to this.
DCT is valuated quite expensively with a Price/Forward Earnings ratio of 96.14.
DCT's Price/Forward Earnings is on the same level as the industry average.
DCT is valuated expensively when we compare the Price/Forward Earnings ratio to 35.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
DCT Price Earnings VS Forward Price EarningsDCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

65.00% of the companies in the same industry are more expensive than DCT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DCT is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 101.39
EV/EBITDA 244.38
DCT Per share dataDCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DCT's earnings are expected to grow with 29.83% in the coming years.
PEG (NY)9
PEG (5Y)N/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%

More info and screens

3

5. Dividend

5.1 Amount

DCT has a Yearly Dividend Yield of 1.26%. Purely for dividend investing, there may be better candidates out there.
DCT's Dividend Yield is rather good when compared to the industry average which is at 37.38. DCT pays more dividend than 86.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, DCT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

DCT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DCT Yearly Dividends per shareDCT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%
DCT Yearly Income VS Free CF VS DividendDCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

More info and screens

Duck Creek Technologies Inc

NASDAQ:DCT (3/29/2023, 8:01:09 PM)

After market: 18.99 0 (0%)

18.99

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-29 2023-03-29/amc
Earnings (Next)06-27 2023-06-27/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.33%
Ins Owner Change0%
Market Cap2.52B
Analysts46.67
Price Target16.47 (-13.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)687.25%
Min EPS beat(2)67.06%
Max EPS beat(2)1307.44%
EPS beat(4)3
Avg EPS beat(4)570.06%
Min EPS beat(4)67.06%
Max EPS beat(4)1307.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.54%
Min Revenue beat(2)4.14%
Max Revenue beat(2)8.94%
Revenue beat(4)3
Avg Revenue beat(4)4.16%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)8.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)5.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.62%
EPS NY rev (1m)0%
EPS NY rev (3m)18.92%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
P/S 8.14
P/FCF 101.39
P/OCF 85.71
P/B 3.45
P/tB 8.57
EV/EBITDA 244.38
EPS(TTM)0.1
EY0.53%
EPS(NY)0.2
Fwd EY1.04%
FCF(TTM)0.19
FCFY0.99%
OCF(TTM)0.22
OCFY1.17%
SpS2.33
BVpS5.5
TBVpS2.22
PEG (NY)9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.63%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.72%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.68
Altman-Z 15.48
F-Score5
WACC12.39%
ROIC/WACCN/A
Cap/Depr(3y)19.14%
Cap/Depr(5y)28.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A
EBIT growth 1Y-38.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.99%
EBIT Next 3Y42.3%
EBIT Next 5YN/A
FCF growth 1Y269.82%
FCF growth 3Y5.03%
FCF growth 5YN/A
OCF growth 1Y151.66%
OCF growth 3Y-10.23%
OCF growth 5YN/A